<?xml version='1.0' encoding='UTF-8'?><rdsi.pacelf.phase3:document xmlns:rdsi.pacelf.phase3='http://www.example.com' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' ><PacELF_ID>2312</PacELF_ID><type>Hardcopy</type><category>Reports and Results</category><hardcopy_location>JCU WHOCC Ichimori collection</hardcopy_location><title>LYMPHATIC FILARIASIS PROGRAMME PROGRESS REPORT TO APRIL 2001</title><description>Overall LF programme progress from GSK perspective</description><year>2001</year><authors>GlaxoSmithKline, Andy Wright</authors><pages>5</pages><work_location>Multicountry Global</work_location><language>English</language><access_rights>Restricted</access_rights><decade>2000</decade></rdsi.pacelf.phase3:document>